U2TH34:BVMF
United Therapeutics Corp Bdr
R$127.00
0.00%
(0.00) 1D
Sep 2, 11:53:07 AM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for U2TH34...
Mkt. cap
20.91B
Avg. vol.
0.00
Volume
0.00
52-wk high
R$155.07
52-wk low
R$105.71
Shares outstanding
42.89M
No. of employees
1K
Mkt. cap
20.91B
Avg. vol.
0.00
Volume
0.00
52-wk high
R$155.07
52-wk low
R$105.71
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
NH Business Review
·
1 day ago
Merrimack Anheuser-Busch Property purchased by United Therapeutics Corporation
Yahoo Finance
·
3 days ago
United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp Bdr
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com